5) end-points, including efficacy outcomes [HbA1c, body weight, FPG, 2 h postprandial glucose (2 h PG), SBP, DBP, waist circumference, and lipid levels] and safety outcomes (hypoglycaemia, nausea, diarrhoea, vomiting, injection site-related events, urinary tract infection, genital infection etc.)
Additionally, using Mounjaro with other similar medications, such as other GLP-1 receptor agonists, is not recommended due to the potential for excessive side effects and no added benefits
This key feature aids in Retatrutide dose planning and inventory management
broader therapeutic scope
Cravings and hunger naturally decrease, making lifestyle changes more manageable
Most studies on the role of mitochondria in synaptic transmission have focused on the organelles presynaptic pool